These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 19390629)

  • 1. PPARγ2 polymorphism and human health.
    He W
    PPAR Res; 2009; 2009():849538. PubMed ID: 19390629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasting plasma free fatty acid concentrations and Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPAR) gamma2 gene in healthy individuals.
    Vaccaro O; Mancini FP; Ruffa G; Sabatino L; Iovine C; Masulli M; Colantuoni V; Riccardi G
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):481-6. PubMed ID: 12354130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 with decreased basic metabolic rate in women with polycystic ovary syndrome.
    Koika V; Marioli DJ; Saltamavros AD; Vervita V; Koufogiannis KD; Adonakis G; Decavalas G; Georgopoulos NA
    Eur J Endocrinol; 2009 Aug; 161(2):317-22. PubMed ID: 19465486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction effect between common polymorphisms in PPARgamma2 (Pro12Ala) and insulin receptor substrate 1 (Gly972Arg) on insulin sensitivity.
    Stumvoll M; Stefan N; Fritsche A; Madaus A; Tschritter O; Koch M; Machicao F; Häring H
    J Mol Med (Berl); 2002 Jan; 80(1):33-8. PubMed ID: 11862322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Pro12Ala polymorphism in peroxisome proliferator-activated receptor-γ2 gene on metabolic syndrome risk: a meta-analysis.
    Zhang R; Wang J; Yang R; Sun J; Chen R; Luo H; Liu D; Cai D
    Gene; 2014 Feb; 535(1):79-87. PubMed ID: 24012868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PPARgamma2 polymorphism pro12Ala is associated with better insulin sensitivity in the offspring of type 2 diabetic patients.
    Jacob S; Stumvoll M; Becker R; Koch M; Nielsen M; Löblein K; Maerker E; Volk A; Renn W; Balletshofer B; Machicao F; Rett K; Häring HU
    Horm Metab Res; 2000 Oct; 32(10):413-6. PubMed ID: 11069206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sibling-based association study of the PPARgamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study. Stanford Asian-Pacific Program in Hypertension and Insulin Resistance.
    Chuang LM; Hsiung CA; Chen YD; Ho LT; Sheu WH; Pei D; Nakatsuka CH; Cox D; Pratt RE; Lei HH; Tai TY
    J Mol Med (Berl); 2001 Nov; 79(11):656-64. PubMed ID: 11715069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity.
    Deeb SS; Fajas L; Nemoto M; Pihlajamäki J; Mykkänen L; Kuusisto J; Laakso M; Fujimoto W; Auwerx J
    Nat Genet; 1998 Nov; 20(3):284-7. PubMed ID: 9806549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARγ2 Pro12Ala Polymorphism is Associated in Children With Traits Related to Susceptibility to Type 2 Diabetes.
    Vales-Villamarín C; de Dios O; Pérez-Nadador I; Gavela-Pérez T; Soriano-Guillén L; Garcés C
    Front Pharmacol; 2021; 12():763853. PubMed ID: 34887761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The peroxisome proliferator activated receptorgamma2 (PPARgamma2) Pro12Ala variant: lack of association with type 2 diabetes in obese and non obese Tunisian patients.
    Zouari Bouassida K; Chouchane L; Jellouli K; Chérif S; Haddad S; Gabbouj S; Danguir J
    Diabetes Metab; 2005 Apr; 31(2):119-23. PubMed ID: 15959417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes.
    Hara K; Okada T; Tobe K; Yasuda K; Mori Y; Kadowaki H; Hagura R; Akanuma Y; Kimura S; Ito C; Kadowaki T
    Biochem Biophys Res Commun; 2000 Apr; 271(1):212-6. PubMed ID: 10777704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of PPARgamma as a thrifty gene both in mice and humans.
    Hara K; Kubota N; Tobe K; Terauchi Y; Miki H; Komeda K; Tamemoto H; Yamauchi T; Hagura R; Ito C; Akanuma Y; Kadowaki T
    Br J Nutr; 2000 Dec; 84 Suppl 2():S235-9. PubMed ID: 11242476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the Pro12Ala polymorphism in the peroxisome proliferator-activated receptor (PPAR) gamma2 gene on the expression of PPARgamma target genes in adipose tissue of massively obese subjects.
    Kolehmainen M; Uusitupa MI; Alhava E; Laakso M; Vidal H
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1717-22. PubMed ID: 12679463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
    Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
    Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional variant in the peroxisome proliferator-activated receptor gamma2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians.
    Muller YL; Bogardus C; Beamer BA; Shuldiner AR; Baier LJ
    Diabetes; 2003 Jul; 52(7):1864-71. PubMed ID: 12829658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of PPARgamma in high-fat diet-induced obesity and insulin resistance.
    Kadowaki T; Hara K; Kubota N; Tobe K; Terauchi Y; Yamauchi T; Eto K; Kadowaki H; Noda M; Hagura R; Akanuma Y
    J Diabetes Complications; 2002; 16(1):41-5. PubMed ID: 11872365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Dynamics Simulation and Essential Dynamics of Deleterious Proline 12 Alanine Single-Nucleotide Polymorphism in PPAR
    Taghvaei S; Saremi L
    PPAR Res; 2022; 2022():3833668. PubMed ID: 35547362
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic polymorphism of Pro12Ala in type 2 diabetes mellitus: Role in inflammation linked to Insulin resistance.
    Bonam VR; Srinivasan AR; DanielDevaprasad M; Kudikala RB
    Bioinformation; 2023; 19(9):946-953. PubMed ID: 37928491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does peroxisome proliferator-activated receptor gamma genotype (Pro12ala) modify the association of physical activity and dietary fat with fasting insulin level?
    Franks PW; Luan J; Browne PO; Harding AH; O'Rahilly S; Chatterjee VK; Wareham NJ
    Metabolism; 2004 Jan; 53(1):11-6. PubMed ID: 14681835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central obesity and body fat, but not body mass index, are associated with the Pro12Ala polymorphism in the peroxisome proliferator-activated receptor γ gene in a population with a high consumption of saturated and trans-fatty acids.
    Aguayo-Armendáriz J; Montalvo-Corral M; González-Martínez KA; Grijalva-Haro MI; Ballesteros-Vásquez MN; Caire-Juvera G; Moya-Camarena SY
    Nutr Res; 2018 Sep; 57():28-35. PubMed ID: 30122193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.